Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 349,282 |
|
|||||
| News | - | ||||||
| Day High | 15.1664 | Low High |
|||||
| Day Low | 14.73 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc | CPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.34 | 2.31% | 15.07 | 12:04:58 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 14.80 | 14.73 | 15.1664 | 14.73 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,897 | 349,282 | $ 15.06 | $ 5,259,238 | - | 11.09 - 17.765 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:04:59 | 49 | $ 15.06 | USD |
Catalyst Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.78B | 117.86M | - | 398.2M | 71.41M | 0.61 | 24.99 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Catalyst Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.70 | 16.25 | 14.73 | 15.22 | 2,457,617 | -0.63 | -4.01% |
| 1 Month | 15.90 | 16.665 | 14.73 | 15.43 | 1,374,979 | -0.83 | -5.22% |
| 3 Months | 14.71 | 17.495 | 13.1161 | 15.30 | 1,362,884 | 0.36 | 2.45% |
| 6 Months | 12.56 | 17.495 | 11.89 | 14.74 | 1,412,462 | 2.51 | 19.98% |
| 1 Year | 16.43 | 17.765 | 11.09 | 14.00 | 1,474,749 | -1.36 | -8.28% |
| 3 Years | 4.58 | 22.11 | 4.43 | 12.39 | 1,619,436 | 10.49 | 229.04% |
| 5 Years | 5.41 | 22.11 | 2.235 | 8.66 | 1,771,513 | 9.66 | 178.56% |
Catalyst Pharmaceuticals Description
| Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome. |
